Buzzy Distraction During Venipuncture

Sponsor
IRCCS Burlo Garofolo (Other)
Overall Status
Completed
CT.gov ID
NCT02969902
Collaborator
(none)
200
2
3

Study Details

Study Description

Brief Summary

Venipuncture is one of the most common iatrogenic painful and stressful procedures performed on children. Interventions aimed at reducing the distress related to this experience are widely and strongly recommended. Pain and anxiety management is even more essential because it may modify children's memory for procedural pain and the subsequent acceptance of later health care painful interventions. Distraction is the most studied psychological technique to relieve venipuncture related pain and distress, with a strong evidence supporting its efficacy in children and adolescents.

In recent years several studies showed the effectiveness of a specific tool named Buzzy® (MMJ Labs, Atlanta GA, USA), in relieving pain and distress in children. Buzzy combines distraction and physical analgesia (vibration and cold) and it was positively tested during venipuncture, intravenous cannulation and painful injections in children. Even though its efficacy it's well established, most of the published trials did not compare Buzzy with other interventions, so that little data are available about its usefulness compared with other distractions techniques.

Hand-held computers are reusable tools, which offer a technological-based active distraction. There is evidence supporting their used during painful procedures such as venipuncture and a recent published study showed that hand-held computer distraction was as effective as nurse-led passive distraction techniques in children.

The aim of this study is to compare the effectiveness of Buzzy versus hand-held computer in pain relief during venipuncture.

Condition or Disease Intervention/Treatment Phase
  • Device: Buzzy® device
  • Device: Hand-held computer
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Randomized Controlled Trial to Compare Buzzy and Hand-held Computer Distraction for Pain Control in Children Underwent Venipuncture.
Study Start Date :
Nov 1, 2014
Actual Primary Completion Date :
Feb 1, 2015
Actual Study Completion Date :
Feb 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Buzzy® device

The Buzzy® device is applied just above the selected site of the venipuncture; an ice pack is attached under the device; the device is turned on and after 15 second the venipuncture is made.

Device: Buzzy® device

Active Comparator: Hand-held computer

Using an hand-held computer, children start to play with an age-appropriate videogame three minutes before the procedure. They continue to play during the venipuncture.

Device: Hand-held computer

Outcome Measures

Primary Outcome Measures

  1. Self-reported pain [Within 5 minutes after the procedure]

    Children from 4 to 7 years of age record their pain using the Faces Pain Scale-Revised (FPS-R); children from 8 to 12 years using a Numerical Rating Scale, with scores from zero to 10.

Secondary Outcome Measures

  1. Pain evaluated by parents [Within 5 minutes after the procedure]

    Pain evaluated using a Numerical Rating Scale, with scores from zero to 10

  2. Pain evaluated by nurses [Within 5 minutes after the procedure]

    Pain evaluated using a Numerical Rating Scale, with scores from zero to 10

  3. Success at first attempt [Intraprocedural]

    Percentage of success at first attempt

  4. Adverse events [Up to 15 minutes after the procedure]

    The number and the type of adverse events

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • children from 4 to 12 years of age needing venipuncture
Exclusion Criteria:
  • the presence of damage, denuded or broken skin in the site of Buzzy application;

  • use of topical, enteral or parenteral analgesics within eight hours before enrolment;

  • the presence of cognitive impairment or the inability to report pain verbally;

  • the presence of chronic disease, included epilepsy, or of diseases associated with cold hypersensitivity (i.e., sickle cell anaemia, Raynaud's disease).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • IRCCS Burlo Garofolo

Investigators

  • Study Chair: Egidio Barbi, MD, IRCCS Burlo Garofolo
  • Study Director: Franca Crevatin, RN, IRCCS Burlo Garofolo

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Luca Ronfani, Head of Clinical Epidemiology and Public Health Research Unit, IRCCS Burlo Garofolo
ClinicalTrials.gov Identifier:
NCT02969902
Other Study ID Numbers:
  • RC 19/13
First Posted:
Nov 21, 2016
Last Update Posted:
Aug 21, 2017
Last Verified:
Aug 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Luca Ronfani, Head of Clinical Epidemiology and Public Health Research Unit, IRCCS Burlo Garofolo

Study Results

No Results Posted as of Aug 21, 2017